Fusen Pharmaceutical Co., Ltd. (HK:1652) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fusen Pharmaceutical Co., Ltd. successfully held its Annual General Meeting (AGM) on May 28, 2024, where all proposed resolutions were overwhelmingly approved by shareholders. Key resolutions included the adoption of audited financial statements, re-election of directors, and the re-appointment of KPMG as auditors. Shareholders also granted the directors general mandates to manage share issuances and repurchases, indicating strong investor support for the company’s governance.
For further insights into HK:1652 stock, check out TipRanks’ Stock Analysis page.